Revvity reported $16.91B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 39.08B 6.43B Jun/2026
Align Technology USD 12.08B 198M Jun/2026
Bio-Rad Laboratories USD 7.87B 390M Jun/2026
Bruker USD 9.16B 3.66B Jun/2026
Charles River Laboratories USD 10.39B 2.54B Jun/2026
Cspc Pharmaceutical CNY 103.79B 16.5B Mar/2026
Danaher USD 138.86B 10.4B Jun/2026
Dentsply International USD 2.13B 191M Jun/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 4.58B 2.8B Mar/2026
Divis Laboratories Ltd INR 1.75T 167.78B Jun/2026
Edwards Lifesciences USD 52.09B 5.92B Jun/2026
Illumina USD 26.71B 8.84B Jun/2026
Intuitive Surgical USD 140.84B 22.89B Jun/2026
IQVIA Holdings USD 32.25B 3.62B Jun/2026
Kangmei Pharma CNY 24.48B 3.45B Mar/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Laboratory Of America USD 22.96B 1.03B Jun/2026
Malin Corporation EUR 133.52M 29.05M Aug/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Mettler Toledo International USD 25.82B 278M Jun/2026
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
OraSure Technologies USD 174M 61M Dec/2025
Organigram Holdings CAD 252.47M 59.69M Mar/2026
Ovoca Bio EUR 1.17M 18.38K Dec/2025
Pacific Biosciences Of California USD 565M 180M Dec/2025
Pharma Mar EUR 1.31B 263.2M Jun/2026
Qiagen NV USD 8.07B 197.36M Jun/2026
Quest Diagnostics USD 23.46B 1.77B Jun/2026
Quidel USD 940M 66M Jun/2026
Repligen USD 7.7B 1.05B Jun/2026
Revvity USD 12.69B 2.75B Jun/2026
Sartorius EUR 15.63B 1.38B Jun/2026
Thermo Fisher Scientific USD 190.65B 7.99B Jun/2026
Waters USD 37.24B 7.38B Jun/2026
Zealand Pharma A/S 20.84B 12.51B Mar/2026
Zz Pientze Pharmaceu CNY 65.93B 25.23B Jun/2026